BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8658638)

  • 1. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
    Kita Y; Iwaki Y; Noguchi K; Griffith BP; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1229-34. PubMed ID: 8658638
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
    Kita Y; Iwaki Y; Noguchi K; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1237-40. PubMed ID: 8658640
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
    Noguchi K; Yoshida Y; Yagihashi A; Kita Y; Takenaka T; Terasawa K; Hayashi S; Konno A; Kobayashi M; Nakamura K
    Transplant Proc; 1992 Jun; 24(3):1152. PubMed ID: 1604565
    [No Abstract]   [Full Text] [Related]  

  • 4. Annual review of transplantation.
    First MR
    Clin Transpl; 1990; ():357-73. PubMed ID: 2129410
    [No Abstract]   [Full Text] [Related]  

  • 5. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 6. Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation.
    Zeevi A; Pavlick M; Banas R; Bentlejewski C; Spichty K; Rao AS; Fontes P; Iyengar A; Shapiro R; Dodson F; Jordan M; Pham S; Keenan R; Griffith B; Corry R; Egidi F; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1205-6. PubMed ID: 9123274
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating adhesion molecules and other soluble markers of immune activation in human small bowel and small bowel plus liver transplantation.
    Satoh S; Thomson AW; Nakamura K; Warty V; Todo S
    Transplant Proc; 1994 Jun; 26(3):1417-8. PubMed ID: 7913263
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts.
    Ibrahim S; Dawson DV; Elmohsen MA; Elsamannoudy FA; Sanfilippo F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):80-3. PubMed ID: 8438488
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated acute cellular rejection of the liver after simultaneous liver and kidney transplantation: a case report.
    Nah YW; Nam CW; Suh JH; Cha HJ; Kim GY; Park SJ; Oh Y; Cho HR
    Transplant Proc; 2008 Oct; 40(8):2832-4. PubMed ID: 18929875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in transplantation and immunosuppressive treatment.
    Manez R
    Drug News Perspect; 2003 Jun; 16(5):332-6. PubMed ID: 12942165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief focus on memory cells in transplantation.
    Le Moine A; Vokaer B; Charbonnier LM
    Transplant Proc; 2009 Oct; 41(8):3361-2. PubMed ID: 19857749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of IL-2, IL-2R, IL-6, and TNF-alpha as a diagnostic test of acute rejection after renal transplantation.
    Cho WH; Kim HT; Sohn CY; Park CH; Park SB; Kim HC
    Transplant Proc; 1998 Nov; 30(7):2967-9. PubMed ID: 9838310
    [No Abstract]   [Full Text] [Related]  

  • 13. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
    Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
    Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of antibody-mediated rejection after kidney transplantation.
    Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
    Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft histology and lymphocyte apoptosis in pancreas allografts combined with liver allografts.
    Li L; Sun J; Wang C; Wang L; Hovart M; Sheil AG
    Transplant Proc; 1998 Nov; 30(7):2956-7. PubMed ID: 9838304
    [No Abstract]   [Full Text] [Related]  

  • 16. The utility of fine-needle aspiration biopsy in organ transplantation.
    Yussim A; Shapira Z; Nakache R; Bar-Nathan N; Shmueli D; Shaharabani E; Burstein A; Or H; Buksenboim G; Lustig S
    Transplant Proc; 1992 Oct; 24(5):1880-1. PubMed ID: 1329285
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in urinary interleukin-2 in kidney transplant recipients.
    Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
    Transplant Proc; 1996 Jun; 28(3):1248-9. PubMed ID: 8658644
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of indirect allorecognition in chronic rejection of human allografts.
    Suciu-Foca N; Liu Z; Colovai AI; Tugulea S; Reed EF; Mancini D; Cohen DJ; Benvenisty AI; Benstein JA; Hardy MA; Schulman LL; Rose EA
    Transplant Proc; 1996 Feb; 28(1):404-5. PubMed ID: 8644291
    [No Abstract]   [Full Text] [Related]  

  • 19. Antirejection strategy in small bowel transplantation.
    Wood RF
    Transplant Proc; 1996 Oct; 28(5):2491-3. PubMed ID: 8907918
    [No Abstract]   [Full Text] [Related]  

  • 20. Allograft vascular disease: comparison of heart and other grafted organs.
    Radio S; Wood S; Wilson J; Lin H; Winters G; McManus B
    Transplant Proc; 1996 Feb; 28(1):496-9. PubMed ID: 8644326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.